Venetoclax and Homoharringtonine‐Based Therapy Exhibited a Striking Response in Refractory/Relapsed Early T‐Cell Precursor Acute Lymphoblastic Leukemia

ABSTRACT Early T‐cell precursor acute lymphoblastic leukemia (ETP‐ALL) is an aggressive subtype of T‐ALL. Once refractory or relapsed, it is associated with a poor prognosis, with a complete remission (CR) rate of 36%–46% following re‐induction therapy. Previously, we reported a synergistic effect o...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Xiang Zhang, Hongsheng Zhou, Liping Mao, Yinjun Lou, Lijing Shen, Ying Lu, Zhenfang Liu, Xiuzhen Tong, Aiping Zhang, Tingbo Liu, Na Zhang, Xingnong Ye, Juying Wei, Meihong Luo, Shaoyuan Wang, Qingxian Bai, Jian Hou, Qifa Liu, Hongyan Tong, Jie Jin, Wenjuan Yu
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Wiley 2025-12-01
Serie:	MedComm
Soggetti:	early T‐cell precursor acute lymphoblastic leukemia refractoriness relapse venetoclax homoharringtonine
Accesso online:	https://doi.org/10.1002/mco2.70549
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!